TherapeuticsMD Shares Spiked After Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD
May 31, 2022 By MarketDepth
TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped about 350% Tuesday after the Company announced that it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners, a private equity firm dedicated to making investments in rapidly growing healthcare companies.
Healthcare Company for Women
TherapeuticsMD is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women.
All Cash Transaction
Under the terms of the transaction, which has been unanimously approved by TXMD’s board of directors, EW Healthcare Partners will commence a tender offer to acquire all outstanding shares of TXMD common stock for $10.00 per share in an all-cash transaction, followed immediately by a merger. The purchase price represents a premium of 367.3% over TherapeuticsMD’s closing share price on May 27, 2022.
“We are very pleased to enter into this agreement with EW Healthcare Partners. Together, we will continue empowering women of all ages through a therapeutic focus in family planning, reproductive health, and menopause management. We have a deep appreciation for EW Healthcare Partners’ depth of expertise and track record and know they will bring an incredible value of knowledge and strategic guidance.”
Hugh O’Dowd, Chief Executive Officer of TherapeuticsMD
“We are pleased to welcome TherapeuticsMD to the EW Healthcare Partners portfolio and are deeply committed to the Company’s mission of advancing women’s health. EW Healthcare Partners has already made a significant investment in women’s health through its acquisition of Majorelle. TherapeuticsMD represents a unique opportunity for Majorelle to enter the US market and is a perfect fit with our ambitious plans to create a fast-growing, premier trans-Atlantic women’s health platform. We bring an extensive network and capital to fund the further growth of the combined company,” said Evis Hursever, Managing Director at EW Healthcare Partners.
